These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 14566462

  • 21. [Cyclosporin A treatment of adult patients with severe nephrotic syndrome].
    Nyrop M, Olgaard K.
    Ugeskr Laeger; 1992 Jul 06; 154(28):1944-8. PubMed ID: 1509556
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Immunosuppressive therapy in primary glomerulonephritis (pros).
    Ponticelli C, Banfi G, Imbasciati E, Tarantino A.
    Contrib Nephrol; 1982 Jul 06; (34):33-54. PubMed ID: 6293765
    [No Abstract] [Full Text] [Related]

  • 24. [Steroids or cytostatics in the juvenile nephrotic syndrome].
    Brodehl J.
    Klin Padiatr; 1972 Jul 06; 184(4):241-9. PubMed ID: 4567556
    [No Abstract] [Full Text] [Related]

  • 25. Tacrolimus as the first-line agent in adult-onset minimal change disease: A randomized controlled study.
    Patil MR, Divyaveer SS, Raychaudhary A, Trivedi M, Mahajan C, Sarkar D, Pandey R.
    Saudi J Kidney Dis Transpl; 2019 Jul 06; 30(1):129-137. PubMed ID: 30804274
    [Abstract] [Full Text] [Related]

  • 26. Clinicopathologic features and treatment response in nephrotic IgA nephropathy with minimal change disease.
    Qin J, Yang Q, Tang X, Chen W, Li Z, Mao H, Jiang Z, Huang F, Yu X.
    Clin Nephrol; 2013 Jan 06; 79(1):37-44. PubMed ID: 22948116
    [Abstract] [Full Text] [Related]

  • 27. [Minimal change nephrotic syndrome].
    Hirayama K, Kobayashi M.
    Nihon Jinzo Gakkai Shi; 2010 Jan 06; 52(7):882-7. PubMed ID: 21077335
    [No Abstract] [Full Text] [Related]

  • 28. [Evaluation of cyclosporin A efficacy in the treatment of steroid-resistant nephrotic syndrome in the course of membranoproliferative glomerulonephritis--case report].
    Zelichowski G, Nowosławski A, Wawer Z, Wańkowicz Z.
    Pol Arch Med Wewn; 2001 Nov 06; 106(5):1065-9. PubMed ID: 12026521
    [Abstract] [Full Text] [Related]

  • 29. Conventional treatment of idiopathic nephrotic syndrome and membranous nephropathy in adults.
    Ponticelli C, Passerini P.
    Clin Nephrol; 1991 Nov 06; 35 Suppl 1():S16-21. PubMed ID: 1860261
    [Abstract] [Full Text] [Related]

  • 30. Steroid responsiveness and frequency of relapse in adult-onset minimal change nephrotic syndrome.
    Nakayama M, Katafuchi R, Yanase T, Ikeda K, Tanaka H, Fujimi S.
    Am J Kidney Dis; 2002 Mar 06; 39(3):503-12. PubMed ID: 11877569
    [Abstract] [Full Text] [Related]

  • 31. Beneficial effect of chlorambucil in steroid-dependent and cyclophosphamide-resistant minimal change nephrotic syndrome.
    Ueda N, Takahashi K, Akioka Y, Morooka M, Ogawa A, Tsuzuki K.
    J Nephrol; 2009 Mar 06; 22(5):610-5. PubMed ID: 19809993
    [Abstract] [Full Text] [Related]

  • 32. Minimal change glomerulonephritis in a 90-year-old patient: what is the ideal approach?
    Norris M, Kissel C, Roy L.
    Nephron; 1996 Mar 06; 73(4):670-3. PubMed ID: 8856267
    [Abstract] [Full Text] [Related]

  • 33. Minimal change disease: a review.
    Saha TC, Singh H.
    South Med J; 2006 Nov 06; 99(11):1264-70. PubMed ID: 17195422
    [Abstract] [Full Text] [Related]

  • 34. Cyclosporin in idiopathic glomerular disease associated with the nephrotic syndrome : workshop recommendations.
    Cattran DC, Alexopoulos E, Heering P, Hoyer PF, Johnston A, Meyrier A, Ponticelli C, Saito T, Choukroun G, Nachman P, Praga M, Yoshikawa N.
    Kidney Int; 2007 Dec 06; 72(12):1429-47. PubMed ID: 17898700
    [Abstract] [Full Text] [Related]

  • 35. Clinical impact of cyclosporine cellular pharmacodynamics in minimal change nephrotic syndrome.
    Hirano T, Akashi T, Keira T, Oka K, Ihoya N, Yoshida M.
    Clin Pharmacol Ther; 2000 Nov 06; 68(5):532-40. PubMed ID: 11103756
    [Abstract] [Full Text] [Related]

  • 36. [Treatment of steroid-dependent minimal change-nephrotic syndrome with mycophenolate mofetil].
    Noroña B, Valentín M, Gutiérrez E, Praga M.
    Nefrologia; 2004 Nov 06; 24(1):79-82. PubMed ID: 15083963
    [Abstract] [Full Text] [Related]

  • 37. Minimal change disease and Kimura's disease responding to tacrolimus therapy.
    Balwani MR, Bawankule CP, Pasari A, Tolani P, Vakil S, Yadav R.
    Saudi J Kidney Dis Transpl; 2019 Nov 06; 30(1):254-257. PubMed ID: 30804291
    [Abstract] [Full Text] [Related]

  • 38. Nephrotic syndrome after stem cell transplantation.
    Stevenson WS, Nankivell BJ, Hertzberg MS.
    Clin Transplant; 2005 Feb 06; 19(1):141-4. PubMed ID: 15659148
    [Abstract] [Full Text] [Related]

  • 39. Current therapeutic strategies in glomerulonephritis.
    Woo KT.
    Ann Acad Med Singap; 1999 Mar 06; 28(2):272-8. PubMed ID: 10497681
    [Abstract] [Full Text] [Related]

  • 40. The changing pattern of glomerulonephritis in Singapore over the past two decades.
    Woo KT, Chiang GS, Pall A, Tan PH, Lau YK, Chin YM.
    Clin Nephrol; 1999 Aug 06; 52(2):96-102. PubMed ID: 10480220
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.